The biggest news about vitamins and supplements is not that most of them fail to prevent disease. It's that 'most' is the honest answer, while the label on the bottle is allowed to imply something far grander. For a healthy adult with no documented deficiency, the best current evidence says a daily multivitamin will not cancel out a poor diet, will not prevent heart disease, and it won't add years to a life that's already well nourished.
That is not a cynical take. It is the finding of one of the most thorough independent reviews ever done on the subject. But a blanket 'supplements are useless' is too simple. The real story is about matching a pill to a measurable problem.
The supplement aisle promises a lot. The evidence tells a different story.
Roughly 58 percent of adults in the United States took a dietary supplement in the past 30 days, according to data from the National Health and Nutrition Examination Survey. Multivitamin-mineral products are the most common. Most users are healthy, and supplement users tend to have better diets than non-users. That makes the research harder to interpret, because the people at lowest baseline risk are often the ones buying the pills.
That last fact may sound like a reason to keep buying. It is closer to a reason to stop. If a body already has enough of a vitamin, extra doses tend to be excreted, stored, or in a handful of cases harmful. Nutrient deficiency is a specific medical problem with a specific treatment. Nutrient abundance is not a disease, and adding more does not move most health outcomes.
Here's the catch
In the United States, a dietary supplement can reach the market without the same premarket safety and efficacy review that a new medicine must survive. The US Food and Drug Administration can act after a product is on sale, but it does not approve most supplements first. Under the Dietary Supplement Health and Education Act of 1994, known as DSHEA, a manufacturer can make a structure/function claim such as 'supports immune health' without proving it to the FDA.
This arrangement flips the usual burden of proof. A pharmaceutical company has to show that a drug works before selling it. A supplement company mostly has to avoid being caught doing something wrong after the product is already on shelves. Regulators in other countries take different approaches; the European Union restricts hundreds of health claims on botanical supplements. The result is that the same bottle can say different things in different places, which is why global advice has to lean on independent trial data rather than shelf talk.
The few nutrients that clear the bar
The strongest data are not about prevention in healthy people. They are about treatment of deficiency or specific high-risk states. Folic acid before and during early pregnancy clearly reduces neural tube defects. Vitamin B12 is the right fix when a B12 deficiency exists, whether from age-related absorption loss or a strict plant-based diet. Iron works when someone is iron-deficient, not merely tired from a busy week.
Then there are conditional cases. Vitamin D with calcium can reduce fractures in older adults who are at risk, but the benefit shrinks in people with normal vitamin D levels. The Vitamin D and Omega-3 Trial, known as VITAL, did not find a major reduction in cardiovascular events from daily vitamin D in generally healthy adults. Omega-3 fatty acids showed a similar overall picture, although secondary results pointed to fewer heart attacks among people with low fish intake.
The US Preventive Services Task Force reviewed the evidence in 2022. It recommended against beta-carotene and vitamin E for preventing cardiovascular disease and cancer. Evidence was insufficient for multivitamins and most other single nutrients. The NIH Office of Dietary Supplements reaches the same sober conclusion in its multivitamin review.
| Evidence level | What it applies to | What the data show |
|---|---|---|
| Strong | Folic acid in early pregnancy | Reduces neural tube defects; dose and timing matter. |
| Strong | B12 for confirmed deficiency | Corrects deficiency and prevents neurological damage in deficient people. |
| Conditional | Omega-3 fatty acids | No major overall cardiovascular benefit in a large trial, but possible heart attack reduction with low fish intake. |
| No benefit | Multivitamins for healthy adults | No consistent reduction in heart disease, cancer, or early death in major reviews. |
| Harmful at high doses | Beta-carotene and vitamin E | Increased lung cancer risk in smokers for beta-carotene; increased prostate cancer risk for vitamin E. |
Antioxidants, memory pills, and the high-dose trap
The antioxidant story is the clearest warning. Beta-carotene made biological sense because oxidative stress seemed to drive cancer and ageing. But when researchers tested beta-carotene pills in smokers and workers exposed to asbestos, the supplement groups developed more lung cancer, not less. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study recorded an 18 percent increase in lung cancer among male smokers taking beta-carotene. The CARET trial was stopped early for the same reason. The National Cancer Institute has summarized those findings for anyone who wants the details.
Vitamin E followed a similar arc. The Selenium and Vitamin E Cancer Prevention Trial, known as SELECT, found that healthy men taking vitamin E had a 17 percent higher risk of prostate cancer than those on placebo. More was not neutral. More was worse.
The newer memory research is more modest than the label claims. One randomized trial, COSMOS-Mind, found a small memory benefit among older adults taking a daily multivitamin compared with placebo, equal to roughly three years of age-related memory change. Researchers framed it as promising enough to study further, not enough to change routine practice. That distinction disappears on a supplement bottle.
How to buy when the label will not tell you
Before another bottle, do one thing: identify the need. That usually means a blood test, a dietary pattern, or a life stage. Without a need, most supplements become expensive urine. With a need, the same bottle becomes medicine.
- Ask your clinician whether testing is warranted for B12, vitamin D, iron, or folate before self-diagnosing.
- Start with food. Fatty fish, fortified dairy, leafy greens, and beans cover most nutrient needs in ordinary diets.
- For a confirmed deficiency, choose the specific nutrient at the dose your clinician recommends. A multivitamin can contain too little of what you need and too much of what you do not.
- Look for third-party verification from USP, NSF International, or ConsumerLab. It does not prove benefit, but it reduces the risk of contamination and dose label mismatch.
- Report every supplement and herbal product to your pharmacist and doctor. Interactions with warfarin, other blood thinners, and some medications are common.
What the research actually reveals is not a single verdict on all vitamins and supplements. It reveals that the default question, 'should I take something?', is the wrong one. The better question is what am I missing, how do I know, and what dose brings me back to normal. Ask that in a pharmacy and half the shelf quietly loses its relevance. Large trial investigators keep saying it in drier language: the benefits cluster in people who start out deficient, and the harms cluster in people who take more than they need.
Photo by Supliful - Supplements On Demand on Unsplash